TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RYTM

Rhythm Pharmaceuticals Inc

Healthcare · Biotechnology

92.80$ -0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RYTM
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.45 1.34 2.13 2.92
– – 0.00 0.00 0.01 0.01 0.01 0.02 0.02 0.01 0.04 0.16 0.22 0.30
– – 0.00 0.00 -0.01 -0.01 -0.01 -0.02 -0.02 0.05 0.41 1.18 1.91 2.62
0.31 0.36 0.52 0.70 1.17 0.86 1.62 3.01 2.05 2.10 2.08 2.34 3.90 2.58
0.05 0.07 0.12 0.34 0.38 0.36 0.91 1.00 1.05 1.38 1.77 1.93 2.37 3.00
0.36 0.43 0.64 1.04 1.55 1.21 2.53 4.01 3.10 3.48 3.85 4.38 6.27 5.57
-0.36 -0.43 -0.64 -1.04 -1.55 -1.21 -2.53 -4.01 -3.10 -3.43 -3.44 -3.20 -4.35 -2.95
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.03 0.10 0.24 0.34 0.32
-0.36 -0.43 -0.64 -1.09 -1.55 -1.26 -2.39 -3.86 -3.04 -1.40 -3.47 -3.19 -4.27 -3.02
– – 0.00 0.00 0.00 0.04 0.14 -0.17 -0.07 -0.03 0.04 0.01 0.01 0.01
-0.36 -0.43 -0.64 -1.09 -1.55 -1.26 -2.39 -3.70 -2.96 -1.37 -3.47 -3.20 -4.27 -3.02
-0.36 -0.43 – -0.99 -1.54 -1.20 -2.51 -3.99 -3.08 -3.41 -3.34 -2.92 -3.90 -2.68

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?